Looking forward, Veeva is expected to see a deceleration in the rate of revenue growth in FY26, which could be due to tougher ...

Major new initiative will add AI to Veeva applications and the Veeva Vault Platform to help automate critical industry-specific functions and improve productivity from clinical to commercial Veeva ...

The year 2025 is witnessing a significant expansion of the Medical Info Systems industry, fueled by new federal policies and strong regulatory support. A major catalyst is Donald Trump's $500 billion ...

In conversation with Fierce Pharma, Anthony Billinger, senior director of Compass Strategy at Veeva Systems, sheds light on the rapidly evolving world of commercial data in life sciences—and why ...

Veeva Systems is overvalued, trading at frothy levels despite only ~10% growth, and facing a potential slowdown in 2025; I recommend a sell rating. The company excels in the life sciences vertical ...

Commercial services player EVERSANA has joined the growing number of companies partnering with Veeva Systems – a specialist in cloud software for the life sciences industry – on the ...

Yet, this upbeat vision is being undercut by another cornerstone of Trump's economic ... 3 Medical Info Systems Stocks to Bet On Veeva Systems offers cloud-based software applications and data ...

In the latest market close, Veeva Systems (VEEV) reached $232.07, with a -0.69% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.63% for the ...